Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 14

Empagliflozin Regulates the AdipoR1/p-AMPK/p-ACC Pathway to Alleviate Lipid Deposition in Diabetic Nephropathy

Total article views   HTML views PDF downloads Totals
8,274 Dovepress* 6,953+ 959 7,912
PubMed Central* 1,321 455 1,776
Totals 8,274 1,414 9,688
*Since 18 January 2021
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 1 3

View citations on PubMed Central and Google Scholar